Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Lari Wenzel"'
Autor:
Jason A. Zell, Thomas H. Taylor, C. Gregory Albers, Joseph C. Carmichael, Christine E. McLaren, Lari Wenzel, Michael J. Stamos
Publikováno v:
Cancers, Vol 15, Iss 7, p 2103 (2023)
After potentially curative treatment, colorectal cancer (CRC) patients remain at high risk for recurrence, second primary CRC, and high-risk adenomas. In combination with existing data, our previous findings provide a rationale for reducing tissue po
Externí odkaz:
https://doaj.org/article/e21f28c120c34b1c91ada2ee4cb22068
Autor:
Kathryn Osann, Lari Wenzel, Chelsea McKinney, Lynne Wagner, David Cella, Giulia Fulci, Mary J. Scroggins, Heather A. Lankes, Victoria Wang, Kenneth P. Nephew, George L. Maxwell, Samuel C. Mok, Thomas P. Conrads, Austin Miller, Michael Birrer
Publikováno v:
Gynecologic Oncology. 171:151-158
Autor:
Kirstie Haywood, Ameeta Retzer, Anita Slade, Melanie Calvert, Jane Blazeby, Rebecca Mercieca-Bebber, Antonia Bennett, Carolyn Ells, Gary Price, Galina Velikova, Heather Draper, Dennis Revicki, Julia Brown, Lori Frank, Madeleine King, Jane Scott, Sandra Mitchell, Grace Turner, Michael Brundage, Andrew Bottomley, Michael Palmer, Richard Stephens, Ingolf Griebsch, Donald Patrick, Lari Wenzel, Daniel O'Connor, Robert M Golub, Olalekan Aiyegbusi, E Basch, Jill Bell, Vishal Bhatnagar, Lisa Campbell, Amylou C Dueck, Amanda Hunn, Bellinda King-Kallimanis, Thomas Morel, Linda Nelson, Josephine Norquist, Antoine Regnault, Antonia Valakas, Maria von Hildebrand, Anita Walker
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on the impact of disease and treatment on patients’ symptoms, function and quality of life. High-quality PRO data from trials can inform shared decision-makin
Externí odkaz:
https://doaj.org/article/781a2d9ef823452cb74c4e858f349f4c
Autor:
Andrea M. Mesiti, Julianna Brouwer, Mehraneh D. Jafari, Yuqing Qiu, Lari Wenzel, Joseph Carmichael, Chelsea McKinney, Jason A. Zell, Alessio Pigazzi
Publikováno v:
Journal of Surgical Research. 283:658-665
Early initiation of chemotherapy after surgery for colon cancer has survival benefits. Immediate adjuvant chemotherapy (IAC) involves giving chemotherapy during surgical resection and immediately postoperatively. This novel approach has been shown to
Autor:
Anamaria R. Yeung, Snehal Deshmukh, Ann H. Klopp, Karen M. Gil, Lari Wenzel, Shannon N. Westin, Andre A. Konski, David K. Gaffney, William Small, J. Spencer Thompson, Desiree E. Doncals, Guilherme H.C. Cantuaria, David P. D'Souza, Amy Chang, Vijayananda Kundapur, Dasarahally S. Mohan, Michael L. Haas, Yong Bae Kim, Catherine L. Ferguson, Stephanie L. Pugh, Lisa A. Kachnic, Deborah W. Bruner
Publikováno v:
Journal of Clinical Oncology. 40:3115-3119
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical Tri
Autor:
David M Gershenson, Austin Miller, William E Brady, James Paul, Karen Carty, William Rodgers, David Millan, Robert L Coleman, Kathleen N Moore, Susana Banerjee, Kate Connolly, Angeles Alvarez Secord, David M O'Malley, Oliver Dorigo, Stephanie Gaillard, Hani Gabra, Brian Slomovitz, Parviz Hanjani, John Farley, Michael Churchman, Ailith Ewing, Robert L Hollis, C Simon Herrington, Helen Q Huang, Lari Wenzel, Charlie Gourley
Publikováno v:
The Lancet. 399:541-553
BACKGROUND: Low-grade serous carcinoma of the ovary or peritoneum is characterised by MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high-grade serous carcinoma. We compared the MEK inhibitor trametinib to physician'
Autor:
Calen W. Kucera, Chunqiao Tian, Christopher M. Tarney, Cassandra Presti, Suzanne Jokajtys, Stuart S. Winkler, Yovanni Casablanca, Nicholas W. Bateman, Paulette Mhawech-Fauceglia, Lari Wenzel, Chad A. Hamilton, John K. Chan, Nathaniel L. Jones, Rodney P. Rocconi, Timothy D. O’Connor, John H. Farley, Craig D. Shriver, Thomas P. Conrads, Neil T. Phippen, G. Larry Maxwell, Kathleen M. Darcy
Publikováno v:
JAMA Network Open. 6:e238437
ImportanceDisparities in survival exist between non-Hispanic Black (hereafter, Black) and non-Hispanic White (hereafter, White) patients with uterine cancer.ObjectiveTo investigate factors associated with racial disparities in survival between Black
Autor:
Oliver Zivanovic, David Cella, Sean C. Dowdy, Summer B. Dewdney, Alexander Melamed, David E. Cohn, Warner K. Huh, Kemi M. Doll, Stephanie L. Wethington, Lari Wenzel, Amanda N. Fader, Jeanne Carter, Vivian E. von Gruenigen, Rachel C. Sisodia
Publikováno v:
Gynecol Oncol
Autor:
Yong Bae Kim, Ann H. Klopp, Michael L. Haas, Spencer Thompson, Lisa A. Kachnic, Guilherme Cantuaria, C.L. Ferguson, Karen M. Gil, Snehal Deshmukh, Lari Wenzel, Deborah Watkins Bruner, Shannon N. Westin, Stephanie L. Pugh, Vijayananda Kundapur, Anamaria R. Yeung, William Small, Desiree E. Doncals, Brian Yaremko, David K. Gaffney, D.S. Mohan, Amy T.Y. Chang
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 15
PURPOSE In oncology trials, the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) is the standard tool for reporting adverse events (AEs), but it may underreport symptoms experienced by patients. This analysis of the NR
Autor:
Ritesh Parajuli, Joshua Levy, Nicole Myers, Chloe Ekelem, Margit Juhasz, Yessica Landaverde, Jamie Fortman, Natasha Atanaskova Mesinkovska, Jessica Lin, Lari Wenzel, Christine Pham
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 4:34-56
Background: Chemotherapy-induced alopecia (CIA) is a common adverse effect of chemotherapy. 8% of patients consider declining chemotherapy due to CIA risk.Objective: To determin whether cancer patients who are actively receiving chemotherapy are inte